Discussion Posts

Thread Subject Replies Last Post Community
Lung Cancer Conferences
   
4 8 days ago by Kevin Chen Thoracic Oncology | Special Interest Group
SQ Amivantamab ARR Monitoring
   
8 16 days ago by Kevin Chen Thoracic Oncology | Special Interest Group
ICI Timing
   
4 21 days ago by Ming-Hei Tai
Original post by Kevin Chen 		Thoracic Oncology | Special Interest Group
Sunvozertinib
   
7 02-02-2026 by Jasmine Patel
Original post by Shelby Quinn 		Thoracic Oncology | Special Interest Group
Tarlatamab handling - haz drug?
   
0 01-20-2026 by Eileen Hamilton Thoracic Oncology | Special Interest Group
RET Inhibitors and Risk of ONJ
   
0 10-14-2025 by Stefanie Houseknecht Thoracic Oncology | Special Interest Group
Tarlatamab and CRRT
   
0 10-02-2025 by Jasmine Patel Thoracic Oncology | Special Interest Group
BiTE (tarlatamab) dysgeusia
   
1 10-01-2025 by Stefanie Houseknecht
Original post by Ashtin Taylor 		Thoracic Oncology | Special Interest Group
2nd line NSCLC EGFR Exon 18 inframe deletion tx options
   
2 09-03-2025 by Kevin Chen
Original post by Kate Fox 		Thoracic Oncology | Special Interest Group
Hyperuricemia with Taletrectinib
   
0 08-15-2025 by Stefanie Houseknecht Thoracic Oncology | Special Interest Group
Showing 1 to 10 of 14 threads (14 total posts)